Cargando…

Microbiota and the Immune System—Actors in the Gastric Cancer Story

SIMPLE SUMMARY: Stomach cancer is one of the most commonly diagnosed cancers in the world. Although the number of new cases is decreasing year by year, the death rate for this type of cancer is still high. The heterogeneous course and the lack of symptoms in the early stages of the disease mean that...

Descripción completa

Detalles Bibliográficos
Autores principales: Majewski, Marek, Mertowska, Paulina, Mertowski, Sebastian, Smolak, Konrad, Grywalska, Ewelina, Torres, Kamil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367521/
https://www.ncbi.nlm.nih.gov/pubmed/35954495
http://dx.doi.org/10.3390/cancers14153832
_version_ 1784765832412266496
author Majewski, Marek
Mertowska, Paulina
Mertowski, Sebastian
Smolak, Konrad
Grywalska, Ewelina
Torres, Kamil
author_facet Majewski, Marek
Mertowska, Paulina
Mertowski, Sebastian
Smolak, Konrad
Grywalska, Ewelina
Torres, Kamil
author_sort Majewski, Marek
collection PubMed
description SIMPLE SUMMARY: Stomach cancer is one of the most commonly diagnosed cancers in the world. Although the number of new cases is decreasing year by year, the death rate for this type of cancer is still high. The heterogeneous course and the lack of symptoms in the early stages of the disease mean that the diagnosis is made late, which translates into a worse prognosis for such patients. That is why it is so important to analyze potential risk factors that may increase the risk of developing gastric cancer and to search for new effective methods of treatment. These requirements are met by the analysis of the composition of the gastric microbiota and its relationship with the immune system, which is a key element in the human anti-cancer fight. This publication was created to systematize the current knowledge on the impact of dysbiosis of human microbiota on the development and progression of gastric cancer. Particular emphasis was placed on taking into account the role of the immune system in this process. ABSTRACT: Gastric cancer remains one of the most commonly diagnosed cancers in the world, with a relatively high mortality rate. Due to the heterogeneous course of the disease, its diagnosis and treatment are limited and difficult, and it is associated with a reduced prognosis for patients. That is why it is so important to understand the mechanisms underlying the development and progression of this cancer, with particular emphasis on the role of risk factors. According to the literature data, risk factors include: changes in the composition of the stomach and intestinal microbiota (microbiological dysbiosis and the participation of Helicobacter pylori), improper diet, environmental and genetic factors, and disorders of the body’s immune homeostasis. Therefore, the aim of this review is to systematize the knowledge on the influence of human microbiota dysbiosis on the development and progression of gastric cancer, with particular emphasis on the role of the immune system in this process.
format Online
Article
Text
id pubmed-9367521
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93675212022-08-12 Microbiota and the Immune System—Actors in the Gastric Cancer Story Majewski, Marek Mertowska, Paulina Mertowski, Sebastian Smolak, Konrad Grywalska, Ewelina Torres, Kamil Cancers (Basel) Review SIMPLE SUMMARY: Stomach cancer is one of the most commonly diagnosed cancers in the world. Although the number of new cases is decreasing year by year, the death rate for this type of cancer is still high. The heterogeneous course and the lack of symptoms in the early stages of the disease mean that the diagnosis is made late, which translates into a worse prognosis for such patients. That is why it is so important to analyze potential risk factors that may increase the risk of developing gastric cancer and to search for new effective methods of treatment. These requirements are met by the analysis of the composition of the gastric microbiota and its relationship with the immune system, which is a key element in the human anti-cancer fight. This publication was created to systematize the current knowledge on the impact of dysbiosis of human microbiota on the development and progression of gastric cancer. Particular emphasis was placed on taking into account the role of the immune system in this process. ABSTRACT: Gastric cancer remains one of the most commonly diagnosed cancers in the world, with a relatively high mortality rate. Due to the heterogeneous course of the disease, its diagnosis and treatment are limited and difficult, and it is associated with a reduced prognosis for patients. That is why it is so important to understand the mechanisms underlying the development and progression of this cancer, with particular emphasis on the role of risk factors. According to the literature data, risk factors include: changes in the composition of the stomach and intestinal microbiota (microbiological dysbiosis and the participation of Helicobacter pylori), improper diet, environmental and genetic factors, and disorders of the body’s immune homeostasis. Therefore, the aim of this review is to systematize the knowledge on the influence of human microbiota dysbiosis on the development and progression of gastric cancer, with particular emphasis on the role of the immune system in this process. MDPI 2022-08-08 /pmc/articles/PMC9367521/ /pubmed/35954495 http://dx.doi.org/10.3390/cancers14153832 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Majewski, Marek
Mertowska, Paulina
Mertowski, Sebastian
Smolak, Konrad
Grywalska, Ewelina
Torres, Kamil
Microbiota and the Immune System—Actors in the Gastric Cancer Story
title Microbiota and the Immune System—Actors in the Gastric Cancer Story
title_full Microbiota and the Immune System—Actors in the Gastric Cancer Story
title_fullStr Microbiota and the Immune System—Actors in the Gastric Cancer Story
title_full_unstemmed Microbiota and the Immune System—Actors in the Gastric Cancer Story
title_short Microbiota and the Immune System—Actors in the Gastric Cancer Story
title_sort microbiota and the immune system—actors in the gastric cancer story
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367521/
https://www.ncbi.nlm.nih.gov/pubmed/35954495
http://dx.doi.org/10.3390/cancers14153832
work_keys_str_mv AT majewskimarek microbiotaandtheimmunesystemactorsinthegastriccancerstory
AT mertowskapaulina microbiotaandtheimmunesystemactorsinthegastriccancerstory
AT mertowskisebastian microbiotaandtheimmunesystemactorsinthegastriccancerstory
AT smolakkonrad microbiotaandtheimmunesystemactorsinthegastriccancerstory
AT grywalskaewelina microbiotaandtheimmunesystemactorsinthegastriccancerstory
AT torreskamil microbiotaandtheimmunesystemactorsinthegastriccancerstory